| Biomarker ID | 1232 |
| PMID | 24179387 |
| Year | 2011 |
| Biomarker | N-terminal propeptide of collagen type I (PINP) |
| Biomarker Basis | Concentration Based (ng/ml) |
| Biomolecule | Protein |
| Source | Serum |
| Subjects | Humans |
| Regulation | Upregulated in Bone Metastatis |
| Odds Ratio/Hazard Ratio/Relative Risk | NA |
| Effect on Pathways | NA |
| Experiment | Bone Metastatis Vs No Bone Metastatis |
| Type of Biomarker | Prognostic |
| Cohort | 42 prostate cancer patients (25 with Bone Metastatis and without Bone Metastatis) were included |
| Senstivity | NA |
| Specificity | NA |
| AUC | NA |
| Accuracy | NA |
| Level Of Significance | P < 0.001 |
| Method Used | ELISA |
| Clinical | No |
| Remarks | NA |
| Clinical Trial Number | NA |
| Degree Of Validity | Not validated on independent patient dataset |
| Technical Name | NA |